Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic hepatitis B--who should be treated?

Carla S Coffin1, Samuel S Lee

  • 1Liver Unit, Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada.

Medgenmed : Medscape General Medicine
|August 18, 2006
PubMed
Summary

Effective hepatitis B antiviral treatments suppress HBV replication and liver disease remission. This review details current options and criteria for optimal intervention in chronic hepatitis B infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dendrite initiation and deflection in biaxially stressed solid electrolytes.

Nature·2026
Same author

A Gender-Based Descriptive Analysis of the Canadian Network Undertaking Against Hepatitis C (CANUHC) Cohort From 2015-2023.

Open forum infectious diseases·2026
Same author

Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.

The New England journal of medicine·2026
Same author

Reduced wait times for hepatology referrals in a prospective quality improvement initiative.

Hepatology communications·2026
Same author

Optimal timing of infant post-vaccination serological testing for hepatitis B virus immunity.

Canadian liver journal·2026
Same author

Impact of gastrectomy on the risk of alcohol-associated liver disease in patients with gastric cancer.

Scientific reports·2026

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis B virus (HBV) causes acute and chronic infections, affecting 350 million globally.
  • Chronic HBV infection increases risk for cirrhosis and hepatocellular carcinoma (HCC).
  • Lifelong monitoring and effective antiviral treatment are crucial for managing HBV-related complications.

Purpose of the Study:

  • To review current antiviral treatment options for chronic hepatitis B infection.
  • To outline criteria for effective intervention with antiviral therapy.
  • To provide guidance for managing HBV carriers and patients with chronic infection.

Main Methods:

  • Literature review of available hepatitis B antiviral therapies.
  • Analysis of treatment goals, including HBV replication suppression and disease remission.
  • Examination of the natural history of hepatitis B and therapeutic decision-making.

Main Results:

  • Significant advancements in chronic HBV treatment over the past decade.
  • Available treatments include interferon alfa, pegylated interferon, and nucleos(t)ide analogs (lamivudine, adefovir dipivoxil, entecavir).
  • Treatment efficacy depends on understanding HBV natural history and patient-specific factors.

Conclusions:

  • Optimizing antiviral therapy requires a comprehensive understanding of HBV infection.
  • Criteria for intervention guide the selection of appropriate treatment strategies.
  • Effective management aims to prevent long-term liver disease complications and improve patient outcomes.

Related Experiment Videos